Genective S. A. has appointed Bruce Lee, an Australian national as its CEO, with effect from January 1st 2014. Dr. Lee has over 25 years experience in the seed and trait business having previously held senior roles in the public research sector, and in research, licensing, mergers and acquisitions with Syngenta, Basel, Switzerland. Dr. Lee will succeed Dr. Georges Freyssinet who is retiring as the founding CEO of Genective and Dr. Reinhard Nehls (Deputy CEO), who will continue as Head of Research at KWS.
Genective is a technology Joint Venture of two leading global seed companies, the French Groupe Limagrain and the German KWS Group, having its principal office in Paris, France. Genective was established by Limagrain and KWS to collaborate in the field of research, development and marketing of transgenic traits, initially for maize and, potentially at a further stage for other crops.